1,357 results on '"Kulozik, Andreas"'
Search Results
2. Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
3. Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial
4. Gene therapy in transfusion-dependent non-β0/β0 genotype β-thalassemia: first real-world experience of beti-cel
5. Functional analysis of structural variants in single cells using Strand-seq
6. Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
7. Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group
8. Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding
9. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution
10. Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL
11. Final results of the southwest German pilot study on cystic fibrosis newborn screening – Evaluation of an IRT/PAP protocol with IRT-dependent safety net
12. The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β‐thalassaemia and no or low HbA expression
13. DNA methylation-based classification of central nervous system tumours.
14. Anämien
15. Erythrozyten: physiologische Besonderheiten im Kindesalter
16. Differential Analysis of the Nuclear and the Cytoplasmic RNA Interactomes in Living Cells
17. The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma
18. NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
19. Funktionsstörungen des Hämoglobins und Polyzythämie
20. Sustained Efficacy and Safety in Adult and Pediatric Patients with Transfusion-Dependent β-Thalassemia up to 9 Years Post Treatment with Betibeglogene Autotemcel (Beti-cel)
21. Betibeglogene Autotemcel Gene Therapy in Patients with Transfusion-Dependent, Severe Genotype β‑Thalassaemia: Results from the HGB-212 (Northstar-3) Study
22. Cui Bono? Identifying Patient Groups That May Benefit From Granulocyte Transfusions in Pediatric Hematology and Oncology
23. Single-cell analysis of structural variations and complex rearrangements with tri-channel processing
24. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma
25. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
26. Sarcoma classification by DNA methylation profiling
27. Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
28. Funktionsstörungen des Hämoglobins und Polyzythämie
29. Erythrozyten: physiologische Besonderheiten im Kindesalter
30. Anämien
31. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia
32. P350: DAB1 EXPRESSION DRIVES PROLIFERATION AND METABOLIC ACTIVITY IN T-ALL AND INTERFERES WITH T-CELL-SPECIFIC PATHWAYS
33. PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107
34. P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)
35. Bone marrow failure unresponsive to bone marrow transplant is caused by mutations in thrombopoietin
36. Haematological malignancies following temozolomide treatment for paediatric high-grade glioma
37. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia
38. Newborn screening for severe combined immunodeficiency using a novel and simplified method to measure T-cell excision circles (TREC)
39. Chromatin accessibility landscape of pediatric T‐lymphoblastic leukemia and human T‐cell precursors
40. Erythrozyten: physiologische Besonderheiten im Kindesalter
41. Funktionsstörungen des Hämoglobins und Polyzythämie bei Kindern und Jugendlichen
42. Anämien bei Kindern und Jugendlichen
43. Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial
44. Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction
45. Supplementary Figure 5 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
46. Supplementary Figure 8 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
47. Supplementary Figure 1 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
48. Supplementary Figure 9 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
49. Supplementary Tables from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
50. Supplementary Figure 7 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.